Davis T A, Horning S J
Division of Medical Oncology, Stanford University Medical Center, CA 94305, USA.
Curr Opin Hematol. 1998 Jul;5(4):259-63. doi: 10.1097/00062752-199807000-00005.
Recent developments in the management of lymphoma continue to refine our approach to the disease. There is increasing acceptance of the International Lymphoma Study Group classification for non-Hodgkin's lymphoma. Identification of a new viral agent associated with certain subtypes of lymphoma and new immunologic therapies change our perspective on the disease. New data on treatment results further elucidate the role of radiotherapy and high-dose therapy in Hodgkin's disease and the non-Hodgkin's lymphomas.
淋巴瘤治疗的最新进展不断完善我们对该疾病的治疗方法。国际淋巴瘤研究组对非霍奇金淋巴瘤的分类越来越被认可。一种与某些淋巴瘤亚型相关的新型病毒因子的发现以及新的免疫疗法改变了我们对该疾病的看法。关于治疗结果的新数据进一步阐明了放射治疗和高剂量治疗在霍奇金病和非霍奇金淋巴瘤中的作用。
